Andrew Callos
Vermogen: 4 M $ op 31-05-2026
Vermogen: 4 M $ op 31-05-2026
Andrew M.
Callos is Chief Commercial Officer & Executive VP at Cytokinetics, Inc. since 2021.
Formerly, Mr. Callos was Vice President-US Cardiology & Metabolic Marketing at Pfizer Inc. and Assistant Vice President-Marketing at Wyeth Pharmaceuticals, Inc. Mr. Callos completed undergraduate education at Drexel University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-06-2026 | 58.555 ( 0,05% ) | 4 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | 01-03-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | - |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Verkoop & Marketing | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Cytokinetics, Inc.
Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Drexel University
Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau